Story at a glance

  • “We think literally within the next 24 to 48 hours Americans should start receiving shots in arms,” Gorsky said.
  • “We’re shipping 4 million [doses],” Gorsky said, adding, “we’re committed to doing 100 million by June of this year and up to a billion by the end of 2021.”
  • The Johnson & Johnson vaccine was granted emergency use authorization by the Food and Drug Administration on Saturday, becoming the third vaccine in the U.S. to receive approval.

Americans are expected to begin receiving Johnson & Johnson’s single-dose COVID-19 vaccine within the next day or two, after the shot was granted approval over the weekend. 

“We think literally within the next 24 to 48 hours Americans should start receiving shots in arms. They’re literally rolling out with the trucks as we speak,” Alex Gorsky, chairman and CEO of Johnson & Johnson, said during an interview with NBC’s “Today” show Monday. 


Our country is in a historic fight against the Coronavirus. Add Changing America to your Facebook or Twitter feed to stay on top of the news.


“We’re shipping 4 million [doses],” Gorsky said, adding, “we’re committed to doing 100 million by June of this year and up to a billion by the end of 2021.” 


The Johnson & Johnson vaccine was granted emergency use authorization by the Food and Drug Administration (FDA) on Saturday, becoming the third vaccine in the U.S. to receive approval. 

Unlike the Pfizer-BioNTech and Moderna vaccines, Johnson & Johnson’s vaccine is administered in a single dose and does not require deep-freeze storage. Overall, the vaccine has proven to be 66 percent effective at preventing moderate to severe COVID-19 in adults. The efficacy rate among the U.S. population was higher at 72 percent. 

“It works 85 percent of the time against severe disease, and it kept all of the patients out of the hospital and from dying, even against these new and very challenging variants,” Gorsky said Monday. 

Gorsky said Johnson & Johnson will soon start studying the safety of the vaccine in pregnant women and children over the age of 12. 

The addition of a third safe and effective COVID-19 vaccine comes as the U.S. has administered more than 75 million doses of the Pfizer and Moderna vaccine as of Sunday, according to the Centers for Disease Control and Prevention


WHAT YOU NEED TO KNOW ABOUT CORONAVIRUS RIGHT NOW

CALIFORNIA CORONAVIRUS VARIANT IS MORE CONTAGIOUS, NEW RESEARCH SHOWS

A NEW COVID-19 VARIANT IS EMERGING IN NEW YORK CITY, RESEARCHERS SAY

SURPRISING NEW COVID-19 STUDY FINDS VIRUS SURVIVES ON CLOTHING FABRIC FOR DAYS

NEW STUDY SUGGESTS FEW COVID-19 DEATHS OUTSIDE OF WUHAN IN EARLY 2020

HOW COVID-19 VARIANTS STACK UP AGAINST THE VACCINES


 

Published on Mar 01, 2021